Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global vascular ulcer treatment demand is expected to rise at a CAGR of 4.7%. The market revenue is likely to be valued at US$ 2,737.4 million in 2023 and exhibit a revenue growth of US$ 4,344 million by 2033. Rising cases of obesity, coupled with changing lifestyles of people, are increasing the rates of chronic illnesses, such as diabetes and vascular disease. These factors are anticipated to accelerate the vascular ulcer treatment sector.
However, lack of awareness of the benefits of the treatment and lack of skilled healthcare professionals serve as critical challenges for the market.
On the other hand, demand for compression hosiery products is expected to spur due to the high rates of recurrence after healing. This poses revenue opportunities for the vascular ulcer treatment market share.
Multi-component and two-layer compression therapy systems replacing traditional treatment options have provided clinicians the ease of bandage applications and products that deliver effective therapeutic compression. This is expected to significantly accelerate the market growth.
The preference for home care settings for the geriatric population to treat ulcers is likely to expand the market size. In addition to this, initiatives to improve the knowledge and competence about ulcer treatments for nursing staff by reliable social care service organizations are beneficial.
Trained staff offering personalized wound care products, along with the increasing number of specialty clinics with advanced facilities, is likely to expand the market at considerable growth. The rise in the hospitalization rate and increasing healthcare infrastructure is anticipated to surge the demand for vascular ulcer treatment.
Inflammation and pain in patients are attempted to be reduced by electrical stimulation and electroceuticals, which improves clinical numbers. This is further expected to accelerate the market trends.
What are the Drawbacks of Vascular Ulcer Treatment?
The vascular ulcer treatment market share is likely to obstruct due to the high costs of the products associated with the treatments. Moreover, the risk of developing new ulcers in different areas of the body is the result of prolonged surgical care, which is expected to hamper the vascular ulcer treatment industry’s size.
Lack of awareness about treatment options, as well as limited availability of healthcare professionals in underdeveloped nations, is anticipated to hinder the market growth. Furthermore, visa cancellations during the pandemic, causing a hiatus for the medical tourism sector, negatively impacted the market share.
Attributes | Details |
---|---|
Vascular Ulcer Treatment Market CAGR (2023 to 2033) | 4.7% |
Vascular Ulcer Treatment Market Size (2023) | US$ 2,737.4 million |
Vascular Ulcer Treatment Market Size (2033) | US$ 4,344 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for vascular ulcer treatment reached from US$ 2,341.91 million in 2018 to US$ 2,638.5 million in 2022, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 3%.
The increasing prevalence of hypertension and peripheral vascular treatment disease are expected to surge the demand for vascular ulcer treatment. Moreover, rising awareness about innovative dressings and bio-skin treatments to provide relief to patients is likely to expand the market size.
The rising geriatric population, and the knees and hip replacement surgery implemented following previous leg surgeries, are expected to boost the market growth. Furthermore, mergers and acquisitions among market players contribute to the vascular ulcer treatment industry.
Combining different modalities for a more efficient ulcer treatment, increasing in popularity presents a key driver for the market. Likewise, the availability of different skin substitutes and technologically advanced wound care products further surges the demand.
A growing number of product launches and approvals through government initiatives are expected to increase the vascular ulcer treatment business. Research and development (R&D) activities to initiate new strategies and innovations positively impact the market.
New Launches:
Introduction of stockings for the testament of vascular leg ulcers and advanced compression is likely to expand the compression therapy segment. Adoption of these products and services is expected to present lucrative opportunities for the vascular ulcer treatment market.
Health Programs:
The therapeutic effects of compression hosiery products following vascular ulcer treatment are encouraging grace professionals to introduce health programs. This, along with dressings experiencing a dramatic surge in bulk orders, are likely to boost the market growth.
Clinical Evidence:
High availability of published clinical evidence concerning negative pressure wound therapy products is estimated to increase the market share. The growth of the vascular ulcer treatment sector is attributed to the increasing number of clinical trials.
Vascular Ulcer Treatment Market:
Attributes | Vascular Ulcer Treatment Market |
---|---|
CAGR (2023 to 2033) | 4.7% |
Market Value (2023) | US$ 4,344 million |
Growth Factor | Preference for homecare settings |
Opportunity | Increasing number of clinical trials |
Trends | Rising awareness and changing lifestyle |
Vascular Access System Market:
Attributes | Vascular Access System Market |
---|---|
CAGR (2023 to 2033) | 6.6% |
Market Value (2023) | US$ 9,615.32 million |
Growth Factor | Surging number of vascular access surgeries |
Opportunity | Adoption of central venous catheter |
Trends | Cumulative aging population |
Vascular Closure Devices Market:
Attributes | Vascular Closure Devices Market |
---|---|
CAGR (2023 to 2033) | 5.4% |
Market Value (2023) | US$ 2,529.60 million |
Growth Factor | Rapid expansion in healthcare |
Opportunity | Development of minimally invasive techniques |
Trends | Increase in age related cardiac ailments |
Countries | Market Share (2023) |
---|---|
United States | 29.2% |
Germany | 5.9% |
Japan | 5.5% |
North America holds the dominant vascular ulcer treatment industry share, with a revenue of 37.1%. This is owing to the public initiatives related to diabetes and its rising cases.
Launching innovative products by key market participants significantly contributes to global market growth. Research and development activities on technologically advanced products to improve the treatment of these diseases are expected to positively impact the market.
With a revenue of 27.9%, Europe is the second leading vascular ulcer treatment industry. This is owing to the rapidly growing geriatric population and high medical insurer reimbursement rates in this region.
Technological developments and the growing trend to combine different modalities for more systematic ulcer treatments. Moreover, the increase in demand for active wound care products is attributed to the rising prevalence of chronic and acute wounds, especially in the United Kingdom. Due to this, the United Kingdom is expected to have a CAGR of 3.6% by 2033.
Countries | CAGR (2023 to 2033) |
---|---|
India | 5.6% |
China | 4.7% |
The Asia-Pacific is expected to witness significant market growth owing to approvals and product launches. Government initiatives further expand the market size. The geriatric population increasing in number, along with the rise in healthcare infrastructure in various countries of this region, is likely to expand the market size.
In addition to this, the increasing prevalence of diabetes, as well as a significant growth in the disposable income of the middle-class population, further boosts the global demand for the treatment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The expansion of the vascular ulcer treatment market size is owing to the substantial growth during the forecast period, with the prevalence of chronic skin ulcers and diabetes. Hence, start-up companies have taken a keen interest in developing alternative solutions for ulcer treatments through new innovations and strategies.
These are a few of the many start-up companies coming up with various strategies for ulcer treatments, such as peripheral thrombectomy space with a novel flow restoration technology, wearable compression devices, etc.
On the other hand, key market players strive to remain at the top with innovative plans through collaborations, and extensive research and development activities. Rising cases of chronic ulcers provide lucrative options for market players to devise strategies for the improvement and adoption of vascular ulcer treatments.
A leading provider of minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease, and oncology. The global company has over 1200 employees and currently reaches more than 50 markets via direct sales and distributors.
They offer high quality and innovative offerings in medical compression therapy. Their portfolio caters to a wide range of different needs and indications. They are a reliable partner for their customers around the world, that includes pharmacies, DMEs, orthopedic and medical specialist stores, as well as medical professionals and hospitals.
They are significantly growing in biomedical engineering, where they display maximum strength and ability. They provide ground-breaking healthcare technology solutions for the most complex and challenging conditions.
They have a dedication to produce products that provide genuine solutions to real world problems, or products that simply speed up processes to make tasks and surgeries easier. From personal protective equipment to adhesives and insulation-displacement connectors.
Recent Developments:
The market is expected to rise at a CAGR of 4.7% from 2023 to 2033.
Telemedicine for remote patient monitoring is the key trend in the market.
Advanced wound care products segment is the current market leader.
Growing elderly population and incidence of vascular and diabetic illnesses driving the market.
North America, Europe, and Asia Pacific are prominent regions in the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Arterial Ulcers 5.3.2. Neurotrophic Ulcers 5.3.3. Venous Ulcers 5.3.4. Diabetic Ulcers 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033 6.3.1. Compression 6.3.2. Gradual Compression 6.3.3. Intermittent Pneumatic Compression 6.3.4. Drugs 6.3.5. Antibiotics 6.3.6. Pentoxifylline 6.3.7. Topical Steroids 6.3.8. Aspirin 6.3.9. Dressings 6.3.10. Surgical Therapy 6.3.11. Skin Grafting 6.4. Y-o-Y Growth Trend Analysis By Treatment, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Treatment, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 7.3.1. Hospital Pharmacies 7.3.2. Retail Pharmacies 7.3.3. Online Pharmacies & E-Commerce 7.3.4. Drugstores 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Type 9.2.3. By Treatment 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Treatment 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Type 10.2.3. By Treatment 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Treatment 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Type 11.2.3. By Treatment 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Treatment 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Type 12.2.3. By Treatment 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Treatment 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Type 13.2.3. By Treatment 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Treatment 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Type 14.2.3. By Treatment 14.2.4. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Treatment 14.3.4. By Distribution Channel 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Type 15.2.3. By Treatment 15.2.4. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Treatment 15.3.4. By Distribution Channel 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Type 16.1.2.2. By Treatment 16.1.2.3. By Distribution Channel 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Type 16.2.2.2. By Treatment 16.2.2.3. By Distribution Channel 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Type 16.3.2.2. By Treatment 16.3.2.3. By Distribution Channel 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Type 16.4.2.2. By Treatment 16.4.2.3. By Distribution Channel 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Type 16.5.2.2. By Treatment 16.5.2.3. By Distribution Channel 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Type 16.6.2.2. By Treatment 16.6.2.3. By Distribution Channel 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Type 16.7.2.2. By Treatment 16.7.2.3. By Distribution Channel 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Type 16.8.2.2. By Treatment 16.8.2.3. By Distribution Channel 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Type 16.9.2.2. By Treatment 16.9.2.3. By Distribution Channel 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Type 16.10.2.2. By Treatment 16.10.2.3. By Distribution Channel 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Type 16.11.2.2. By Treatment 16.11.2.3. By Distribution Channel 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Type 16.12.2.2. By Treatment 16.12.2.3. By Distribution Channel 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Type 16.13.2.2. By Treatment 16.13.2.3. By Distribution Channel 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Type 16.14.2.2. By Treatment 16.14.2.3. By Distribution Channel 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Type 16.15.2.2. By Treatment 16.15.2.3. By Distribution Channel 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Type 16.16.2.2. By Treatment 16.16.2.3. By Distribution Channel 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Type 16.17.2.2. By Treatment 16.17.2.3. By Distribution Channel 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Type 16.18.2.2. By Treatment 16.18.2.3. By Distribution Channel 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Type 16.19.2.2. By Treatment 16.19.2.3. By Distribution Channel 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Type 16.20.2.2. By Treatment 16.20.2.3. By Distribution Channel 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Type 16.21.2.2. By Treatment 16.21.2.3. By Distribution Channel 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Type 16.22.2.2. By Treatment 16.22.2.3. By Distribution Channel 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Type 16.23.2.2. By Treatment 16.23.2.3. By Distribution Channel 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Type 17.3.3. By Treatment 17.3.4. By Distribution Channel 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Angiodynamics 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Sigvaris Global 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Medi GmbH & Co. KG 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Activa Healthcare 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. 3M 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Medtronic 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. B. Braun Melsungen AG 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Bristol Myers Squibb Co 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Sanofi 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Bayer AG 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Pfizer Inc 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Novo Nordisk A/S 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Cadila Pharmaceuticals Ltd. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Cardinal Health 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. Paul Hartmann AG 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.16. Coloplast Corporation 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 18.1.17. KCI Licensing Inc. 18.1.17.1. Overview 18.1.17.2. Product Portfolio 18.1.17.3. Profitability by Market Segments 18.1.17.4. Sales Footprint 18.1.17.5. Strategy Overview 18.1.17.5.1. Marketing Strategy 18.1.18. Smith & Nephew plc 18.1.18.1. Overview 18.1.18.2. Product Portfolio 18.1.18.3. Profitability by Market Segments 18.1.18.4. Sales Footprint 18.1.18.5. Strategy Overview 18.1.18.5.1. Marketing Strategy 18.1.19. Integra LifeSciences Corporation 18.1.19.1. Overview 18.1.19.2. Product Portfolio 18.1.19.3. Profitability by Market Segments 18.1.19.4. Sales Footprint 18.1.19.5. Strategy Overview 18.1.19.5.1. Marketing Strategy 18.1.20. Mölnlycke Health Care AB 18.1.20.1. Overview 18.1.20.2. Product Portfolio 18.1.20.3. Profitability by Market Segments 18.1.20.4. Sales Footprint 18.1.20.5. Strategy Overview 18.1.20.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Western Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 15: Western Europe Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Eastern Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 19: Eastern Europe Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 20: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033 Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2018 to 2033 Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 17: Global Market Attractiveness by Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Treatment, 2023 to 2033 Figure 19: Global Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Type, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 37: North America Market Attractiveness by Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Treatment, 2023 to 2033 Figure 39: North America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Treatment, 2023 to 2033 Figure 59: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Western Europe Market Value (US$ Million) by Type, 2023 to 2033 Figure 62: Western Europe Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 63: Western Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Western Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 71: Western Europe Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 74: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 75: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 77: Western Europe Market Attractiveness by Type, 2023 to 2033 Figure 78: Western Europe Market Attractiveness by Treatment, 2023 to 2033 Figure 79: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Eastern Europe Market Value (US$ Million) by Type, 2023 to 2033 Figure 82: Eastern Europe Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 83: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 94: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 97: Eastern Europe Market Attractiveness by Type, 2023 to 2033 Figure 98: Eastern Europe Market Attractiveness by Treatment, 2023 to 2033 Figure 99: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia and Pacific Market Value (US$ Million) by Type, 2023 to 2033 Figure 102: South Asia and Pacific Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 103: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 117: South Asia and Pacific Market Attractiveness by Type, 2023 to 2033 Figure 118: South Asia and Pacific Market Attractiveness by Treatment, 2023 to 2033 Figure 119: South Asia and Pacific Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: East Asia Market Value (US$ Million) by Type, 2023 to 2033 Figure 122: East Asia Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 123: East Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 129: East Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 137: East Asia Market Attractiveness by Type, 2023 to 2033 Figure 138: East Asia Market Attractiveness by Treatment, 2023 to 2033 Figure 139: East Asia Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 141: Middle East and Africa Market Value (US$ Million) by Type, 2023 to 2033 Figure 142: Middle East and Africa Market Value (US$ Million) by Treatment, 2023 to 2033 Figure 143: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2023 to 2033 Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2018 to 2033 Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2023 to 2033 Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2023 to 2033 Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033 Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033 Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033 Figure 157: Middle East and Africa Market Attractiveness by Type, 2023 to 2033 Figure 158: Middle East and Africa Market Attractiveness by Treatment, 2023 to 2033 Figure 159: Middle East and Africa Market Attractiveness by Distribution Channel, 2023 to 2033 Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports